speb/financial-data huggingface dataset:
RXST balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 2045000.00
RXST balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 2045000.00
RXST balance_sheet (annual, 2023-12-31) — Current Liabilities: 20903000.00
RXST cash_flow (annual, 2023-12-31) — Depreciation: 4078000.00
RXST cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 4078000.00
RXST cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 4078000.00
RXST income_statement (annual, 2023-12-31) — Diluted Average Shares: 34455111.00
RXST income_statement (annual, 2023-12-31) — Diluted EPS: -1.41
RXST income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -48608000.00
RXST income_statement (annual, 2023-12-31) — EBIT: -45280000.00
RXST income_statement (annual, 2023-12-31) — EBITDA: -41202000.00
RXST cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 6000.00
RXST cash_flow (annual, 2023-12-31) — End Cash Position: 10403000.00
RXST cash_flow (annual, 2023-12-31) — Financing Cash Flow: 61524000.00
RXST balance_sheet (annual, 2023-12-31) — Finished Goods: 8092000.00
RXST cash_flow (annual, 2023-12-31) — Free Cash Flow: -46407000.00
RXST balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -5000.00
RXST balance_sheet (annual, 2023-12-31) — Gross PPE: 35983000.00
RXST income_statement (annual, 2023-12-31) — Gross Profit: 53765000.00
RXST cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 8000.00
RXST income_statement (annual, 2023-12-31) — Interest Expense: 3308000.00
RXST income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 3308000.00
RXST income_statement (annual, 2023-12-31) — Interest Income: 6574000.00
RXST income_statement (annual, 2023-12-31) — Interest Income Non Operating: 6574000.00
RXST cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 3464000.00
RXST balance_sheet (annual, 2023-12-31) — Interest Payable: 0.00
RXST balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -496000.00
RXST balance_sheet (annual, 2023-12-31) — Inventory: 17421000.00
RXST balance_sheet (annual, 2023-12-31) — Invested Capital: 160362000.00
RXST cash_flow (annual, 2023-12-31) — Investing Cash Flow: -22129000.00
RXST cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 105957000.00
RXST cash_flow (annual, 2023-12-31) — Issuance Of Debt: 20000000.00
RXST balance_sheet (annual, 2023-12-31) — Leases: 11553000.00
RXST balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1211000.00
RXST balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1211000.00
RXST cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 20000000.00
RXST cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -60153000.00
RXST balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 17490000.00
RXST cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 105957000.00
RXST income_statement (annual, 2023-12-31) — Net Income: -48608000.00
RXST income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -48608000.00
RXST income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -48608000.00
RXST income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -48608000.00
RXST income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -48608000.00
RXST cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -48608000.00
RXST income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -48608000.00
RXST income_statement (annual, 2023-12-31) — Net Interest Income: 3266000.00
RXST cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -17315000.00
RXST cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -40153000.00
RXST cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -40153000.00
RXST income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 3266000.00
RXST cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -4280000.00
RXST balance_sheet (annual, 2023-12-31) — Net PPE: 13285000.00
RXST cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -4814000.00
RXST balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 160362000.00
RXST income_statement (annual, 2023-12-31) — Normalized EBITDA: -39433000.00
RXST income_statement (annual, 2023-12-31) — Normalized Income: -46839000.00
RXST cash_flow (annual, 2023-12-31) — Operating Cash Flow: -41593000.00
RXST cash_flow (annual, 2023-12-31) — Operating Gains Losses: 1769000.00
RXST income_statement (annual, 2023-12-31) — Operating Income: -50085000.00
RXST income_statement (annual, 2023-12-31) — Operating Revenue: 89077000.00
RXST balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 36139513.00
RXST balance_sheet (annual, 2023-12-31) — Other Current Assets: 3523000.00
RXST balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 2557000.00
RXST balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -5000.00
RXST income_statement (annual, 2023-12-31) — Other Income Expense: -1769000.00
RXST cash_flow (annual, 2023-12-31) — Other Non Cash Items: 287000.00
RXST balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 858000.00
RXST balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 74000.00
RXST balance_sheet (annual, 2023-12-31) — Other Properties: 4605000.00
RXST balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 117490000.00
RXST income_statement (annual, 2023-12-31) — Other Special Charges: 1769000.00
RXST balance_sheet (annual, 2023-12-31) — Payables: 3863000.00
RXST balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 3863000.00
RXST balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 10637000.00
RXST balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
RXST income_statement (annual, 2023-12-31) — Pretax Income: -48588000.00
RXST balance_sheet (annual, 2023-12-31) — Properties: 0.00
RXST cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 164000.00
RXST cash_flow (annual, 2023-12-31) — Purchase Of Investment: -272315000.00
RXST cash_flow (annual, 2023-12-31) — Purchase Of PPE: -4814000.00
RXST balance_sheet (annual, 2023-12-31) — Raw Materials: 5680000.00
RXST balance_sheet (annual, 2023-12-31) — Receivables: 20281000.00
RXST income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 35312000.00
RXST income_statement (annual, 2023-12-31) — Reconciled Depreciation: 4078000.00
RXST cash_flow (annual, 2023-12-31) — Repayment Of Debt: -60153000.00
RXST income_statement (annual, 2023-12-31) — Research And Development: 29051000.00
RXST balance_sheet (annual, 2023-12-31) — Retained Earnings: -594640000.00
RXST cash_flow (annual, 2023-12-31) — Sale Of Investment: 255000000.00
RXST income_statement (annual, 2023-12-31) — Selling General And Administration: 74799000.00
RXST balance_sheet (annual, 2023-12-31) — Share Issued: 36139513.00
RXST income_statement (annual, 2023-12-31) — Special Income Charges: -1769000.00
RXST cash_flow (annual, 2023-12-31) — Stock Based Compensation: 15746000.00
RXST balance_sheet (annual, 2023-12-31) — Stockholders Equity: 160362000.00
RXST balance_sheet (annual, 2023-12-31) — Tangible Book Value: 160362000.00
RXST income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
RXST income_statement (annual, 2023-12-31) — Tax Provision: 20000.00
RXST income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
RXST balance_sheet (annual, 2023-12-31) — Total Assets: 182550000.00
RXST balance_sheet (annual, 2023-12-31) — Total Capitalization: 160362000.00
RXST balance_sheet (annual, 2023-12-31) — Total Debt: 3012000.00
RXST balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 160362000.00
RXST income_statement (annual, 2023-12-31) — Total Expenses: 139162000.00
RXST balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 22188000.00
RXST balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 14143000.00
RXST balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1285000.00
RXST income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -50085000.00
RXST income_statement (annual, 2023-12-31) — Total Unusual Items: -1769000.00
RXST income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1769000.00
RXST balance_sheet (annual, 2023-12-31) — Work In Process: 4145000.00
RXST balance_sheet (annual, 2023-12-31) — Working Capital: 147504000.00
RXST balance_sheet (quarterly, 2024-09-30) — Current Accrued Expenses: 17323000.00
RXST cash_flow (quarterly, 2024-09-30) — Interest Paid Supplemental Data: 5000.00
RXST cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
RXST cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
RXST income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
RXST income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
RXST income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
RXST income_statement (annual, 2024-12-31) — +Operating Expense: 135801000.00
RXST income_statement (annual, 2024-12-31) — +Total Revenue: 139927000.00
RXST balance_sheet (annual, 2024-12-31) — Accounts Payable: 4544000.00
RXST balance_sheet (annual, 2024-12-31) — Accounts Receivable: 30050000.00
RXST balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -25428000.00
RXST balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -25428000.00
RXST balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 903127000.00
RXST cash_flow (annual, 2024-12-31) — Amortization Of Securities: -8977000.00
RXST income_statement (annual, 2024-12-31) — Basic Average Shares: 38867726.00
RXST income_statement (annual, 2024-12-31) — Basic EPS: -0.71
RXST cash_flow (annual, 2024-12-31) — Beginning Cash Position: 10403000.00
RXST cash_flow (annual, 2024-12-31) — Capital Expenditure: -5440000.00
RXST balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 12296000.00
RXST balance_sheet (annual, 2024-12-31) — Capital Stock: 40000.00
RXST balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 16706000.00
RXST balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 237223000.00
RXST cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 123319000.00
RXST cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -99311000.00
RXST cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -16946000.00
RXST cash_flow (annual, 2024-12-31) — Change In Account Payable: 946000.00
RXST cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 5869000.00
RXST cash_flow (annual, 2024-12-31) — Change In Inventory: -4993000.00
RXST cash_flow (annual, 2024-12-31) — Change In Payable: 946000.00
RXST cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 6815000.00
RXST cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -1181000.00
RXST cash_flow (annual, 2024-12-31) — Change In Receivables: -9803000.00
RXST cash_flow (annual, 2024-12-31) — Change In Working Capital: -9162000.00
RXST cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -9803000.00
RXST cash_flow (annual, 2024-12-31) — Changes In Cash: 7062000.00
RXST balance_sheet (annual, 2024-12-31) — Common Stock: 40000.00
RXST balance_sheet (annual, 2024-12-31) — Common Stock Equity: 281238000.00
RXST cash_flow (annual, 2024-12-31) — Common Stock Issuance: 128916000.00
RXST balance_sheet (annual, 2024-12-31) — Construction In Progress: 1543000.00
RXST balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 1543000.00
RXST income_statement (annual, 2024-12-31) — Cost Of Revenue: 40984000.00
RXST balance_sheet (annual, 2024-12-31) — Current Assets: 293823000.00
RXST balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 974000.00
RXST balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 974000.00
RXST balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 3110000.00
RXST balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 3110000.00
RXST balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 3110000.00
RXST balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 3110000.00
RXST balance_sheet (annual, 2024-12-31) — Current Liabilities: 25876000.00
RXST cash_flow (annual, 2024-12-31) — Depreciation: 3575000.00
RXST cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 3575000.00
RXST cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 3575000.00
RXST income_statement (annual, 2024-12-31) — Diluted Average Shares: 38867726.00
RXST income_statement (annual, 2024-12-31) — Diluted EPS: -0.71
RXST income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -27455000.00
RXST income_statement (annual, 2024-12-31) — EBIT: -27384000.00
RXST income_statement (annual, 2024-12-31) — EBITDA: -23809000.00
RXST cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -9000.00
RXST cash_flow (annual, 2024-12-31) — End Cash Position: 17456000.00
RXST cash_flow (annual, 2024-12-31) — Financing Cash Flow: 123319000.00
RXST balance_sheet (annual, 2024-12-31) — Finished Goods: 12029000.00
RXST cash_flow (annual, 2024-12-31) — Free Cash Flow: -22386000.00
RXST balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 166000.00
RXST balance_sheet (annual, 2024-12-31) — Gross PPE: 49058000.00
RXST income_statement (annual, 2024-12-31) — Gross Profit: 98943000.00
RXST cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 24000.00
RXST income_statement (annual, 2024-12-31) — Interest Expense: 21000.00
RXST income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 21000.00
RXST income_statement (annual, 2024-12-31) — Interest Income: 9474000.00
RXST income_statement (annual, 2024-12-31) — Interest Income Non Operating: 9474000.00
RXST cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 0.00
RXST cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 5000.00
RXST balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -613000.00
RXST balance_sheet (annual, 2024-12-31) — Inventory: 22009000.00
RXST balance_sheet (annual, 2024-12-31) — Invested Capital: 281238000.00
RXST cash_flow (annual, 2024-12-31) — Investing Cash Flow: -99311000.00
RXST cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 128916000.00
RXST cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
RXST cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
RXST balance_sheet (annual, 2024-12-31) — Leases: 14246000.00
RXST balance_sheet (quarterly, 2024-12-31) — Leases: 14246000.00
RXST balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 11322000.00
RXST balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 11322000.00
RXST cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
RXST cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
RXST cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -61000.00
RXST balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 19445000.00
RXST balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 19445000.00
RXST cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 128916000.00
RXST income_statement (annual, 2024-12-31) — Net Income: -27455000.00
RXST income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -27455000.00
RXST income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -27455000.00
RXST income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -27455000.00
RXST income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -27455000.00
RXST cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -27455000.00
RXST income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -27455000.00
RXST income_statement (annual, 2024-12-31) — Net Interest Income: 9453000.00
RXST cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -93871000.00
RXST cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -61000.00
RXST cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -61000.00
RXST income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 9453000.00
RXST cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -5536000.00
RXST balance_sheet (annual, 2024-12-31) — Net PPE: 23630000.00
RXST cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -5440000.00
RXST balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 281238000.00
RXST income_statement (annual, 2024-12-31) — Normalized EBITDA: -23809000.00
RXST income_statement (annual, 2024-12-31) — Normalized Income: -27455000.00
RXST cash_flow (annual, 2024-12-31) — Operating Cash Flow: -16946000.00
RXST income_statement (annual, 2024-12-31) — Operating Income: -36858000.00
RXST income_statement (annual, 2024-12-31) — Operating Revenue: 139927000.00
RXST balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 40428220.00
RXST balance_sheet (annual, 2024-12-31) — Other Current Assets: 4541000.00
RXST balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 2788000.00
RXST balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 2788000.00
RXST balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 166000.00
RXST balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1110000.00
RXST balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 127000.00
RXST balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 127000.00
RXST balance_sheet (annual, 2024-12-31) — Other Properties: 13824000.00
RXST balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 220517000.00
RXST balance_sheet (annual, 2024-12-31) — Payables: 4544000.00
RXST balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 4544000.00
RXST balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 14460000.00
RXST balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 14460000.00
RXST balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
RXST income_statement (annual, 2024-12-31) — Pretax Income: -27405000.00
RXST balance_sheet (annual, 2024-12-31) — Properties: 0.00
RXST cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 438000.00
RXST cash_flow (annual, 2024-12-31) — Purchase Of Investment: -336871000.00
RXST cash_flow (annual, 2024-12-31) — Purchase Of PPE: -5440000.00
RXST balance_sheet (annual, 2024-12-31) — Raw Materials: 7109000.00
RXST balance_sheet (annual, 2024-12-31) — Receivables: 30050000.00
RXST income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 40984000.00
RXST income_statement (annual, 2024-12-31) — Reconciled Depreciation: 3575000.00
RXST cash_flow (annual, 2024-12-31) — Repayment Of Debt: -61000.00
RXST income_statement (annual, 2024-12-31) — Research And Development: 34367000.00
RXST balance_sheet (annual, 2024-12-31) — Retained Earnings: -622095000.00
RXST cash_flow (annual, 2024-12-31) — Sale Of Investment: 243000000.00
RXST income_statement (annual, 2024-12-31) — Selling General And Administration: 101434000.00
RXST balance_sheet (annual, 2024-12-31) — Share Issued: 40428220.00
RXST income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
RXST income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
RXST cash_flow (annual, 2024-12-31) — Stock Based Compensation: 24635000.00
RXST balance_sheet (annual, 2024-12-31) — Stockholders Equity: 281238000.00
RXST balance_sheet (annual, 2024-12-31) — Tangible Book Value: 281238000.00
RXST income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
RXST income_statement (annual, 2024-12-31) — Tax Provision: 50000.00
RXST income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
RXST balance_sheet (annual, 2024-12-31) — Total Assets: 318563000.00
RXST balance_sheet (annual, 2024-12-31) — Total Capitalization: 281238000.00
RXST balance_sheet (annual, 2024-12-31) — Total Debt: 12296000.00
RXST balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 281238000.00
RXST income_statement (annual, 2024-12-31) — Total Expenses: 176785000.00
RXST balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 37325000.00
RXST balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 24740000.00
RXST balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 11449000.00
RXST income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -36858000.00
RXST income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
RXST income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
RXST income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
RXST income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
RXST balance_sheet (annual, 2024-12-31) — Work In Process: 3484000.00
RXST balance_sheet (annual, 2024-12-31) — Working Capital: 267947000.00
RXST income_statement (quarterly, 2025-03-31) — +Operating Expense: 39003000.00
RXST income_statement (quarterly, 2025-03-31) — +Total Revenue: 37895000.00
RXST balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 7111000.00
RXST balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 30958000.00
RXST balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 909545000.00
RXST cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -2411000.00
RXST income_statement (quarterly, 2025-03-31) — Basic Average Shares: 40509646.00
RXST income_statement (quarterly, 2025-03-31) — Basic EPS: -0.20
RXST cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 17456000.00
RXST cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -575000.00
RXST balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 12042000.00
RXST balance_sheet (quarterly, 2025-03-31) — Capital Stock: 41000.00
RXST balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 28000000.00
RXST balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 229341000.00
RXST cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -735000.00
RXST cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 20855000.00
RXST cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -8832000.00
RXST cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2226000.00
RXST cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -6163000.00
RXST cash_flow (quarterly, 2025-03-31) — Change In Inventory: -1597000.00
RXST cash_flow (quarterly, 2025-03-31) — Change In Payable: 2226000.00
RXST cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -3937000.00
RXST cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 254000.00
RXST cash_flow (quarterly, 2025-03-31) — Change In Receivables: -928000.00
RXST cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -6208000.00
RXST cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -928000.00
RXST cash_flow (quarterly, 2025-03-31) — Changes In Cash: 11288000.00
RXST balance_sheet (quarterly, 2025-03-31) — Common Stock: 41000.00
RXST balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 279316000.00
RXST cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 696000.00
RXST income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 9566000.00
RXST balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 14575000.00
RXST balance_sheet (quarterly, 2025-03-31) — Current Assets: 288414000.00
RXST balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1055000.00
RXST balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1055000.00
RXST balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 22741000.00
RXST cash_flow (quarterly, 2025-03-31) — Depreciation: 785000.00
RXST cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 785000.00
RXST cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 785000.00
RXST income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 40509646.00
RXST income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.20
RXST income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -8190000.00
RXST income_statement (quarterly, 2025-03-31) — EBIT: -8166000.00
RXST income_statement (quarterly, 2025-03-31) — EBITDA: -7381000.00
RXST cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 6000.00
RXST cash_flow (quarterly, 2025-03-31) — End Cash Position: 28750000.00
RXST cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -735000.00
RXST balance_sheet (quarterly, 2025-03-31) — Finished Goods: 13222000.00
RXST cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -9407000.00
RXST balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 15000.00
RXST balance_sheet (quarterly, 2025-03-31) — Gross PPE: 23479000.00
RXST income_statement (quarterly, 2025-03-31) — Gross Profit: 28329000.00
RXST cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 3000.00
RXST income_statement (quarterly, 2025-03-31) — Interest Expense: 6000.00
RXST income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 6000.00
RXST income_statement (quarterly, 2025-03-31) — Interest Income: 2508000.00
RXST income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 2508000.00
RXST cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 5000.00
RXST balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -579000.00
RXST balance_sheet (quarterly, 2025-03-31) — Inventory: 23574000.00
RXST balance_sheet (quarterly, 2025-03-31) — Invested Capital: 279316000.00
RXST cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 20855000.00
RXST cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 696000.00
RXST balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 10987000.00
RXST balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 10987000.00
RXST cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -13000.00
RXST cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 696000.00
RXST income_statement (quarterly, 2025-03-31) — Net Income: -8190000.00
RXST income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -8190000.00
RXST income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -8190000.00
RXST income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -8190000.00
RXST income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -8190000.00
RXST cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -8190000.00
RXST income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -8190000.00
RXST income_statement (quarterly, 2025-03-31) — Net Interest Income: 2502000.00
RXST cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 21430000.00
RXST cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -13000.00
RXST cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -13000.00
RXST income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 2502000.00
RXST cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1418000.00
RXST balance_sheet (quarterly, 2025-03-31) — Net PPE: 23479000.00
RXST cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -575000.00
RXST balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 279316000.00
RXST income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -7381000.00
RXST income_statement (quarterly, 2025-03-31) — Normalized Income: -8190000.00
RXST cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -8832000.00
RXST income_statement (quarterly, 2025-03-31) — Operating Income: -10674000.00
RXST income_statement (quarterly, 2025-03-31) — Operating Revenue: 37895000.00
RXST balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 40588540.00
RXST balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 4541000.00
RXST balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 15000.00
RXST balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1151000.00
RXST balance_sheet (quarterly, 2025-03-31) — Other Properties: 10922000.00
RXST balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 201341000.00
RXST balance_sheet (quarterly, 2025-03-31) — Payables: 7111000.00
RXST balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 21686000.00
RXST balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
RXST income_statement (quarterly, 2025-03-31) — Pretax Income: -8172000.00
RXST balance_sheet (quarterly, 2025-03-31) — Properties: 12557000.00
RXST cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 52000.00
RXST cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -38570000.00
RXST cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -575000.00
RXST balance_sheet (quarterly, 2025-03-31) — Raw Materials: 7241000.00
RXST balance_sheet (quarterly, 2025-03-31) — Receivables: 30958000.00
RXST income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 9566000.00
RXST income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 785000.00
RXST cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -13000.00
RXST income_statement (quarterly, 2025-03-31) — Research And Development: 10367000.00
RXST balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -630285000.00
RXST cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 60000000.00
RXST income_statement (quarterly, 2025-03-31) — Selling General And Administration: 28636000.00
RXST balance_sheet (quarterly, 2025-03-31) — Share Issued: 40588540.00
RXST cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 7140000.00
RXST balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 279316000.00
RXST balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 279316000.00
RXST income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
RXST income_statement (quarterly, 2025-03-31) — Tax Provision: 18000.00
RXST income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
RXST balance_sheet (quarterly, 2025-03-31) — Total Assets: 313044000.00
RXST balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 279316000.00
RXST balance_sheet (quarterly, 2025-03-31) — Total Debt: 12042000.00
RXST balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 279316000.00
RXST income_statement (quarterly, 2025-03-31) — Total Expenses: 48569000.00
RXST balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 33728000.00
RXST balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 24630000.00
RXST balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 10987000.00
RXST income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -10674000.00
RXST balance_sheet (quarterly, 2025-03-31) — Work In Process: 3690000.00
RXST balance_sheet (quarterly, 2025-03-31) — Working Capital: 265673000.00
RXST income_statement (quarterly, 2025-06-30) — +Operating Expense: 39193000.00
RXST income_statement (quarterly, 2025-06-30) — +Total Revenue: 33637000.00
RXST balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 3348000.00
RXST balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 28058000.00
RXST balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 920159000.00
RXST cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -2130000.00
RXST income_statement (quarterly, 2025-06-30) — Basic Average Shares: 40743786.00
RXST income_statement (quarterly, 2025-06-30) — Basic EPS: -0.29
RXST cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 28750000.00
RXST cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1537000.00
RXST balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 11715000.00
RXST balance_sheet (quarterly, 2025-06-30) — Capital Stock: 41000.00
RXST balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 40355000.00
RXST balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 227491000.00
RXST cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 2065000.00
RXST cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 14652000.00
RXST cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -4376000.00
RXST cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -3717000.00
RXST cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 1033000.00
RXST cash_flow (quarterly, 2025-06-30) — Change In Inventory: -2705000.00
RXST cash_flow (quarterly, 2025-06-30) — Change In Payable: -3717000.00
RXST cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -2684000.00
RXST cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1488000.00
RXST cash_flow (quarterly, 2025-06-30) — Change In Receivables: 2888000.00
RXST cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -1013000.00
RXST cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 2888000.00
RXST cash_flow (quarterly, 2025-06-30) — Changes In Cash: 12341000.00
RXST balance_sheet (quarterly, 2025-06-30) — Common Stock: 41000.00
RXST balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 278012000.00
RXST cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 2068000.00
RXST income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 8447000.00
RXST balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 15934000.00
RXST balance_sheet (quarterly, 2025-06-30) — Current Assets: 283874000.00
RXST balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1101000.00
RXST balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1101000.00
RXST balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 20383000.00
RXST cash_flow (quarterly, 2025-06-30) — Depreciation: 776000.00
RXST cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 776000.00
RXST cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 776000.00
RXST income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 40743786.00
RXST income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.29
RXST income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -11786000.00
RXST income_statement (quarterly, 2025-06-30) — EBIT: -11749000.00
RXST income_statement (quarterly, 2025-06-30) — EBITDA: -10973000.00
RXST cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 14000.00
RXST cash_flow (quarterly, 2025-06-30) — End Cash Position: 41105000.00
RXST cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 2065000.00
RXST balance_sheet (quarterly, 2025-06-30) — Finished Goods: 15960000.00
RXST cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -5913000.00
RXST balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -117000.00
RXST balance_sheet (quarterly, 2025-06-30) — Gross PPE: 23843000.00
RXST income_statement (quarterly, 2025-06-30) — Gross Profit: 25190000.00
RXST cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 67000.00
RXST income_statement (quarterly, 2025-06-30) — Interest Expense: 5000.00
RXST income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 5000.00
RXST income_statement (quarterly, 2025-06-30) — Interest Income: 2254000.00
RXST income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 2254000.00
RXST balance_sheet (quarterly, 2025-06-30) — Inventories Adjustments Allowances: -1673000.00
RXST balance_sheet (quarterly, 2025-06-30) — Inventory: 25061000.00
RXST balance_sheet (quarterly, 2025-06-30) — Invested Capital: 278012000.00
RXST cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 14652000.00
RXST cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 2068000.00
RXST balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 10614000.00
RXST balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 10614000.00
RXST cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -3000.00
RXST cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 2068000.00
RXST income_statement (quarterly, 2025-06-30) — Net Income: -11786000.00
RXST income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -11786000.00
RXST income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -11786000.00
RXST income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -11786000.00
RXST income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -11786000.00
RXST cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -11786000.00
RXST income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -11786000.00
RXST income_statement (quarterly, 2025-06-30) — Net Interest Income: 2249000.00
RXST cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 16189000.00
RXST cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -3000.00
RXST cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -3000.00
RXST income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 2249000.00
RXST cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
RXST balance_sheet (quarterly, 2025-06-30) — Net PPE: 23843000.00
RXST cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1537000.00
RXST balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 278012000.00
RXST income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -10973000.00
RXST income_statement (quarterly, 2025-06-30) — Normalized Income: -11786000.00
RXST cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -4376000.00
RXST income_statement (quarterly, 2025-06-30) — Operating Income: -14003000.00
RXST income_statement (quarterly, 2025-06-30) — Operating Revenue: 33637000.00
RXST balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 40913380.00
RXST balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3264000.00
RXST balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -117000.00
RXST balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1292000.00
RXST balance_sheet (quarterly, 2025-06-30) — Other Properties: 10588000.00
RXST balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 187136000.00
RXST balance_sheet (quarterly, 2025-06-30) — Payables: 3348000.00
RXST balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 19282000.00
RXST balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
RXST income_statement (quarterly, 2025-06-30) — Pretax Income: -11754000.00
RXST balance_sheet (quarterly, 2025-06-30) — Properties: 13255000.00
RXST cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 1230000.00
RXST cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -33811000.00
RXST cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1537000.00
RXST balance_sheet (quarterly, 2025-06-30) — Raw Materials: 6806000.00
RXST balance_sheet (quarterly, 2025-06-30) — Receivables: 28058000.00
RXST income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 8447000.00
RXST income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 776000.00
RXST cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -3000.00
RXST income_statement (quarterly, 2025-06-30) — Research And Development: 10217000.00
RXST balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -642071000.00
RXST cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 50000000.00
RXST income_statement (quarterly, 2025-06-30) — Selling General And Administration: 28976000.00
RXST balance_sheet (quarterly, 2025-06-30) — Share Issued: 40913380.00
RXST cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 8547000.00
RXST balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 278012000.00
RXST balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 278012000.00
RXST income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
RXST income_statement (quarterly, 2025-06-30) — Tax Provision: 32000.00
RXST income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
RXST balance_sheet (quarterly, 2025-06-30) — Total Assets: 309009000.00
RXST balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 278012000.00
RXST balance_sheet (quarterly, 2025-06-30) — Total Debt: 11715000.00
RXST balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 278012000.00
RXST income_statement (quarterly, 2025-06-30) — Total Expenses: 47640000.00
RXST balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 30997000.00
RXST balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 25135000.00
RXST balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 10614000.00
RXST income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -14003000.00
RXST balance_sheet (quarterly, 2025-06-30) — Work In Process: 3968000.00
RXST balance_sheet (quarterly, 2025-06-30) — Working Capital: 263491000.00
RXST income_statement (quarterly, 2025-09-30) — +Operating Expense: 36405000.00
RXST income_statement (quarterly, 2025-09-30) — +Total Revenue: 30340000.00
RXST balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3377000.00
RXST balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 24151000.00
RXST balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 927756000.00
RXST cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -2144000.00
RXST income_statement (quarterly, 2025-09-30) — Basic Average Shares: 40965219.00
RXST income_statement (quarterly, 2025-09-30) — Basic EPS: -0.24
RXST cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 41105000.00
RXST cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -581000.00
RXST balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 11565000.00
RXST balance_sheet (quarterly, 2025-09-30) — Capital Stock: 41000.00
RXST balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 29633000.00
RXST balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 227516000.00
RXST cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -530000.00
RXST cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -9004000.00
RXST cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1187000.00
RXST cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -86000.00
RXST cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 1557000.00
RXST cash_flow (quarterly, 2025-09-30) — Change In Inventory: -3955000.00
RXST cash_flow (quarterly, 2025-09-30) — Change In Payable: -86000.00
RXST cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1471000.00
RXST cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 322000.00
RXST cash_flow (quarterly, 2025-09-30) — Change In Receivables: 3907000.00
RXST cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1745000.00
RXST cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 3907000.00
RXST cash_flow (quarterly, 2025-09-30) — Changes In Cash: -10721000.00
RXST balance_sheet (quarterly, 2025-09-30) — Common Stock: 41000.00
RXST balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 275970000.00
RXST cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 131000.00
RXST income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 6113000.00
RXST balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 17621000.00
RXST balance_sheet (quarterly, 2025-09-30) — Current Assets: 283877000.00
RXST balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1293000.00
RXST balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1293000.00
RXST balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 22291000.00
RXST cash_flow (quarterly, 2025-09-30) — Depreciation: 854000.00
RXST cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 854000.00
RXST cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 854000.00
RXST income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 40965219.00
RXST income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.24
RXST income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -9816000.00
RXST income_statement (quarterly, 2025-09-30) — EBIT: -9802000.00
RXST income_statement (quarterly, 2025-09-30) — EBITDA: -8948000.00
RXST cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -2000.00
RXST cash_flow (quarterly, 2025-09-30) — End Cash Position: 30382000.00
RXST cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -530000.00
RXST balance_sheet (quarterly, 2025-09-30) — Finished Goods: 18620000.00
RXST cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -1768000.00
RXST balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 60000.00
RXST balance_sheet (quarterly, 2025-09-30) — Gross PPE: 23372000.00
RXST income_statement (quarterly, 2025-09-30) — Gross Profit: 24227000.00
RXST cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
RXST income_statement (quarterly, 2025-09-30) — Interest Expense: 4000.00
RXST income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 4000.00
RXST income_statement (quarterly, 2025-09-30) — Interest Income: 2376000.00
RXST income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2376000.00
RXST balance_sheet (quarterly, 2025-09-30) — Inventories Adjustments Allowances: -1437000.00
RXST balance_sheet (quarterly, 2025-09-30) — Inventory: 28950000.00
RXST balance_sheet (quarterly, 2025-09-30) — Invested Capital: 275970000.00
RXST cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -9004000.00
RXST cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 131000.00
RXST balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 10272000.00
RXST balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 10272000.00
RXST cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -19000.00
RXST cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 131000.00
RXST income_statement (quarterly, 2025-09-30) — Net Income: -9816000.00
RXST income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -9816000.00
RXST income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -9816000.00
RXST income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -9816000.00
RXST income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -9816000.00
RXST cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -9816000.00
RXST income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -9816000.00
RXST income_statement (quarterly, 2025-09-30) — Net Interest Income: 2372000.00
RXST cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -8423000.00
RXST cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -19000.00
RXST cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -19000.00
RXST income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 2372000.00
RXST cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -642000.00
RXST balance_sheet (quarterly, 2025-09-30) — Net PPE: 23372000.00